Clinical Trial Update: To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 trial evaluating JW0201 added on in patients with Type 2 Diabetes Mellitus. It notes the study has finished, but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JW0201

Snippet

Sponsor: JW Pharmaceutical | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED